Literature DB >> 32203933

Postexercise Hypotension After Muscle Power Training Session in Older Adults With Hypertension.

José Machado Filho, Carlos Leonardo Figueiredo Machado, Hirofumi Tanaka, Rodrigo Ferrari.   

Abstract

The aim of the present study was to determine the acute effects of a muscle power training (PT) session on arterial blood pressure (BP) in older adults with hypertension. Thirteen participants (64 ± 4 years) with essential hypertension were randomly assigned to a PT session and control session without exercise. During PT, the participants performed three sets of eight repetitions at 50% of the one-repetition maximum tests. The concentric phase during each repetition was performed as fast as possible. The systolic BP (post-15 min: -1.7 ± 1.8 mmHg [p = .048; d = 0.22]; post-30 min: -3.6 ± 1.7 mmHg [p = .010; d = 0.48]; post-45 min: -3.3 ± 1.3 mmHg [p = .002; d = 0.42]; post-60 min: -3.9 ± 1.7 mmHg [p = .003; d = 0.49]) and diastolic BP (post-15 min: -1.5 ± 1.5 mmHg [p = .053; d = 0.20]; post-30 min: -2.2 ± 1.7 mmHg [p = .001; d = 0.29]; post-45 min: -2.0 ± 2.0 mmHg [p = .001; d = 0.27]; post-60 min: -2.0 ± 1.3 mmHg [p < .001; d = 0.26]) reductions were observed at all times after the PT session, compared with the preexercise and control session. PT is an effective strategy to acutely reduce BP in older patients with essential hypertension.

Entities:  

Keywords:  exercise; plyometric; resistance training; strength training

Year:  2020        PMID: 32203933     DOI: 10.1123/japa.2019-0050

Source DB:  PubMed          Journal:  J Aging Phys Act        ISSN: 1063-8652            Impact factor:   1.961


  1 in total

1.  Sex Differences in Post-exercise Hypotension, Ambulatory Blood Pressure Variability, and Endothelial Function After a Power Training Session in Older Adults.

Authors:  Leandro de Oliveira Carpes; Lucas Betti Domingues; Renato Schimitt; Sandra C Fuchs; Taha Alhalimi; Hirofumi Tanaka; Rodrigo Ferrari
Journal:  Front Physiol       Date:  2021-07-16       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.